Portfolio
Portfolio

Transave

Forbion Capital Partners co-led Transave's Series B round in December 2002.

Forbion Capital Partners co-led Transave's Series B round in December 2002.

In 2010, the company merged with Insmed Inc. (NASDAQ INSM).

  • Industry Biotech
  • History IPO